95
Participants
Start Date
August 10, 2009
Primary Completion Date
December 31, 2014
Study Completion Date
April 3, 2019
Arm 1- Dose Escalation
AMG 900 is a small molecule inhibitor of aurora kinases A, B and C. AMG 900 will be administered daily for 4 days every 2 weeks (i.e., 4 consecutive days of dosing followed by 10 consecutive days off treatment).
Arm 1- Dose Expansion
AMG 900 is a small molecule inhibitor of aurora kinases A, B and C. AMG 900 will be administered daily for 4 days every 2 weeks (i.e., 4 consecutive days of dosing followed by 10 consecutive days off treatment).
Research Site, Parkville
Research Site, Bentleigh East
Research Site, Kurralta Park
Research Site, Baltimore
Research Site, Tucson
Research Site, Albuquerque
Research Site, Las Vegas
Research Site, Los Angeles
Lead Sponsor
Amgen
INDUSTRY